Beyond PrEP: The Imperative for an HIV Vaccine to End the Epidemic in Africa
Vaccines · 17.07.2026 · 14 (7) · 627
DOI: 10.3390/vaccines14070627 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Vaccines, online erschienen am 17.07.2026. Verfasst von Nicaise Ndembi und 7 weiteren Autor:innen. Beteiligte Einrichtung: International Vaccine Institute, Africa Regional Office, Nyarugenge, 1 KN 78 St, Kigali P.O. Box 3413, Rwanda. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Walter Reed Army Institute of Research, U.S. National Institute of Allergy and Infectious Diseases, NIH, National Institute for Medical Research.
Abstract (Originalsprache)
The era of highly effective pre-exposure prophylaxis (PrEP) has transformed HIV prevention, yet global HIV incidence remains unacceptably high, particularly in sub-Saharan Africa. While antiretroviral-based prevention is critical, persistent structural barriers to access and adherence highlight the urgent need for a complementary preventive HIV vaccine. In this narrative review and perspective, we argue that scientific progress toward an HIV vaccine must be matched by equally ambitious preparedness investments across three domains: manufacturing and supply chains, clinical trial and regulatory infrastructure, and delivery systems and community engagement. Drawing on lessons from the global rollout of PrEP, post-exposure prophylaxis (PEP), and the COVID-19 pandemic response, we outline a five-pillar strategic roadmap. This roadmap focuses on ensuring that a future HIV vaccine reaches the people who need it most from the moment of regulatory authorization, calling for co-investment in diverse platforms, binding advance market commitments, logistical simulation, and proactive planning for post-licensure effectiveness trials. Preparedness is not secondary to science; it is its essential partner.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- International Vaccine Institute, Africa Regional Office, Nyarugenge, 1 KN 78 St, Kigali P.O. Box 3413, Rwanda.
- Oral Health Initiative, Nigerian Institute of Medical Research, Yaba, Lagos 100001, Nigeria.
- Department of Child Dental Health, Obafemi Awolowo University, Ile-Ife 22005, Nigeria.
- Department of Public Health Dentistry, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai 600077, Tamil Nadu, India.
- Mbeya Medical Research Centre, National Institute for Medical Research, Mbeya P.O. Box 2410, Tanzania.
- Makerere University Walter Reed Program, Kampala P.O. Box 16524, Uganda.
ORCID-Profile: Nicaise Ndembi, Morenike O Folayan, Nyanda E Ntinginya, Betty Mwesigwa, Trevor A Crowell, Nyaradzo M Mgodi, Jerome H Kim
Förderung
- Walter Reed Army Institute of Research
- U.S. National Institute of Allergy and Infectious Diseases, NIH
- National Institute for Medical Research
Zitieren
APA
Ndembi, N., Folayan, M. O., Pilorget, A., Ntinginya, N. E., Mwesigwa, B., Crowell, T. A., Mgodi, N. M., & Kim, J. H. (2026). Beyond PrEP: The Imperative for an HIV Vaccine to End the Epidemic in Africa. Vaccines, 14(7), 627. https://doi.org/10.3390/vaccines14070627
Vancouver
Ndembi N, Folayan MO, Pilorget A, Ntinginya NE, Mwesigwa B, Crowell TA, et al. Beyond PrEP: The Imperative for an HIV Vaccine to End the Epidemic in Africa. Vaccines. 2026;14(7):627. doi:10.3390/vaccines14070627
BibTeX
@article{Ndembi2026,
author = {Ndembi, Nicaise and Folayan, Morenike O and Pilorget, Anthony and Ntinginya, Nyanda E and Mwesigwa, Betty and Crowell, Trevor A and Mgodi, Nyaradzo M and Kim, Jerome H},
title = {Beyond PrEP: The Imperative for an HIV Vaccine to End the Epidemic in Africa},
journal = {Vaccines},
year = {2026},
volume = {14},
number = {7},
pages = {627},
doi = {10.3390/vaccines14070627}
}
EUVIMED